targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222
0
0
0 意见·
09/26/23
Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source
显示更多
0 注释
sort 排序方式